Research Catalog

Details

Additional authors

1. Center for Biologics Evaluation and Research (U.S.)

Description

1. ii, 41 pages : digital, PDF file

Alternative title

1. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis c virus (HCV), testing, product disposition, and donor deferral and reentry

Subject

1. Nucleic acids > United States > Testing
2. HIV (Viruses) > Diagnosis > United States
3. Hepatitis C virus > Diagnosis > United States
4. Blood donors > Government policy > United States

Call number

1. GPO Internet HE 20.4802:N 88/3

Note

1. Title from PDF title page (viewed on May 19, 2009).
2. "Draft guidance".
3. "July 2005".

Bibliography (note)

1. Includes bibliographical references (pages 24-25).

System details (note)

1. Mode of access: Internet at the FDA CBER web site. Address as of 5/19/09: http://www.fda.gov/cber/gdlns/nathivhcv.pdf ; current access is available via PURL.

Title

1. Guidance for industry : nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV), testing, product disposition, and donor deferral and reentry.

Publisher

1. Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2005]

Type of content

1. text

Type of medium

1. computer

Type of carrier

1. online resource

System details

1. Mode of access: Internet at the FDA CBER web site. Address as of 5/19/09: http://www.fda.gov/cber/gdlns/nathivhcv.pdf ; current access is available via PURL.

Bibliography

1. Includes bibliographical references (pages 24-25).

Connect to:

1. https://purl.fdlp.gov/GPO/LPS112841

Added author

1. Center for Biologics Evaluation and Research (U.S.)

Gpo item no.

1. 0499-T-02 (online)

Sudoc no.

1. HE 20.4802:N 88/3